How personalized medicine is changing the rules of drug life exclusivity

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.4, 2004-06, pp. : 429-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine

By Vizirianakis I.S.

European Journal of Pharmaceutical Sciences, Vol. 15, Iss. 3, 2002-04 ,pp. : 243-250

Elsevier

Access to resources Recommend Favorite

Editorial: [SNPs of Drug Metabolic Enzymes and Personalized Medicine Part II]

Current Drug Metabolism, Vol. 13, Iss. 7, 2012-09 ,pp. : 951-951

Bentham Science Publishers

Access to resources Recommend Favorite

How can we enable drug discovery informatics for personalized healthcare?

By Scheiber Josef

Expert Opinion on Drug Discovery, Vol. 6, Iss. 3, 2011-03 ,pp. : 219-224

Informa Healthcare

Access to resources Recommend Favorite

Nanotheranostics for personalized medicine

By Kim Tae Hyung Lee Seulki Chen Xiaoyuan

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 3, 2013-04 ,pp. : 257-269

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized medicine

By Chen James J Lin Wei-Jiun Chen Hung-Chia

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 969-980

Future Medicine

Access to resources Recommend Favorite